PositiveID Inks Space Act Agreement with NASA to Develop Firefly Dx | GenomeWeb

NEW YORK (GenomeWeb News) – PositiveID said today that it will collaborate with NASA's Ames Research Center to test the Firefly Dx detection system as a platform for biological research and commercial development.

Under the new Space Act Agreement, NASA will assess the potential ground and space applications of Firefly Dx, while PositiveID will improve the hardware for extreme environments, such as Department of Defense field applications, PositiveID said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.